Miguel Regueiro, MD

In this Healio video exclusive, Miguel Regueiro, MD, shares highlights from his presentation at the GUILD Conference, where he discussed the importance of early, multimodal intervention in perianal fistulizing Crohn’s disease.

Ustekinumab and adalimumab demonstrated equally high rates of clinical remission in biologic-naïve patients with moderate to severe Crohn’s disease through 1 year of treatment, according to results of the SEAVUE study in The Lancet.

In this Healio Gastroenterology video exclusive, Miguel Regueiro, MD, FACG, discussed how anti-TNF therapy should be used as first-line therapy for treatment of inflammatory bowel disease.

LAS VEGAS – In this video exclusive, Miguel Regueiro, MD, discussed a study assessing the risk of severe disease in postoperative patients with Crohn’s disease with isolated anastomotic disease.

In this video exclusive, Miguel Regueiro, MD, discussed a presentation from Digestive Disease Week on the impact of biologics on the prevalence of osteoporosis and bone fractures in patients with inflammatory bowel disease.

In this exclusive video, Miguel Regueiro, MD, from Cleveland Clinic, discusses some of the hot topics from Advances in Inflammatory Bowel Disease 2020, including the rollout of the COVID-19 vaccine.

In this exclusive video, Miguel Regueiro, MD, from Cleveland Clinic, discusses the effort to hold the first virtual Advances in Inflammatory Bowel Diseases conference.

MAUI, Hawaii — In this exclusive video from GUILD Conference 2020, Miguel Regueiro, MD, discusses his presentation on the management of intra-abdominal abscesses in patients with Crohn’s disease.

CLEVELAND — In this exclusive video from the Cleveland Clinic IBD Master Class, Miguel Regueiro, MD, chair of the Department of Gastroenterology, Hepatology and Nutrition at the Cleveland Clinic, discusses the presentation he gave about how to best navigate the forks in the road on how to position therapies for the treatment of inflammatory bowel disease.

ORLANDO — In this exclusive video from Advances in IBD 2018, Miguel Regueiro, MD, chair of the Department of Gastroenterology, Hepatology and Nutrition at the Cleveland Clinic, discusses some of the main aspects and highlights of the meeting.